NRIX
Nurix Therapeutics Inc
23.70$
-1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +15.4% | -12.1% | +63.4% | +0.5% | +30.3% | -8.1% | -3.8% | -11.7% | +31.7% | -7.6% | -15.8% | |
| – | +10.3% | -15.1% | +79.4% | +1.3% | +35.8% | -9.0% | -8.6% | -14.5% | +37.7% | -8.6% | -17.7% | |
| – | +29.1% | -8.8% | +134.5% | -15.2% | +11.1% | -31.0% | +11.0% | -6.9% | +214.8% | -71.2% | -4.9% | |
| – | +11.2% | -15.3% | +81.6% | +1.1% | +36.1% | -9.8% | -11.6% | -11.7% | +38.3% | -8.8% | -18.0% | |
| – | -60.0% | +0.0% | -25.0% | +33.3% | +87.5% | +506.7% | +108.8% | -91.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +108.5% | -7.2% | -2.5% | -2.6% | +4.1% | -5.8% | +7.3% | +4.4% | -0.6% | +3.9% | -14.4% | |
| – | +41.4% | +0.8% | -7.8% | +6.8% | +11.1% | -6.1% | -16.0% | +8.9% | +5.0% | +6.6% | -21.9% | |
| – | +39.7% | -2.4% | +8.5% | -17.4% | +22.3% | -17.2% | -21.1% | -27.6% | -25.5% | +13.4% | +0.6% | |
| – | +192.7% | -7.5% | -52.5% | +39.3% | +193.1% | -26.9% | -29.1% | +44.6% | +30.3% | -8.2% | +18.6% | |
| – | -14.3% | -15.8% | +119.7% | +1.7% | +39.8% | -8.7% | -6.9% | -16.8% | +44.7% | -10.7% | -16.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.5% | +0.4% | +13.6% | +16.7% | +7.7% | +6.6% | +0.4% | +0.3% | +13.0% | +15.8% | +0.9% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.